Clinical Study Results
Where can I learn more about this study?
You can find more information about this study on the websites listed below. If a full report
of the study results is available, it can also be found here.
• www.clinicaltrials.gov. Once you are on the website, type “NCT03244800” into the
“Other Terms” search box and click “Search”.
• www.clinicaltrialsregister.eu. Once you are on the website, click
“Home and Search”, then type “2017-002025-38” in the search box and click
“Search”.
• www.AstraZenecaClinicalTrials.com. Once you are on the website, type
“D5670C00011” into the search box, and click “Find a Study”.
Full study title: A Phase 2, Randomised, Double-Blind, Placebo-Controlled Study to
Evaluate the Efficacy, Safety, Tolerability, and Pharmacokinetics of Different Doses of
MEDI0382 in Overweight and Obese Subjects with Type 2 Diabetes Mellitus
AstraZeneca Protocol number: D5670C00011
MedImmune Limited, a wholly owned subsidiary of AstraZeneca, sponsored this study
and has its headquarters at 1 Medimmune Way, Gaithersburg, MD 20878.
The phone number for the AstraZeneca Information Center is +1-877-240-9479.
Thank you!
Clinical study participants belong to a large community of people who take part in
clinical research around the world. They help researchers answer important health
questions and find medical treatments for participants.
The Center for Information & Study on Clinical Research
Participation (CISCRP) is a non-profit organization
focused on educating and informing the public about
clinical research participation. CISCRP is not involved
in recruiting patients for clinical studies, nor is it
involved in conducting clinical studies.
CISCRP
One Liberty Square, Suite 510
Boston, MA 02109
1-877-MED-HERO
www.ciscrp.org
8
Version: V2.0 12/2018